Antibody-mediated recovery from subcutaneous herpes simplex virus type 2 infection
about
Antibody protects against lethal infection with the neurally spreading reovirus type 3 (Dearing)Relationship of antibody to outcome in neonatal herpes simplex virus infections.Lymphocyte reactivity contributes to protection conferred by specific antibody passively transferred to herpes simplex virus-infected mice.Ontogeny of murine cellular cytotoxicity to herpes simplex virus-infected cells.Sodium lauryl sulfate increases the efficacy of a topical formulation of foscarnet against herpes simplex virus type 1 cutaneous lesions in mice.Efficacies of gel formulations containing foscarnet, alone or combined with sodium lauryl sulfate, against establishment and reactivation of latent herpes simplex virus type 1Prevention and treatment of experimental herpes simplex virus encephalitis with human immune serum globulin.Virus-specific antibodies in sera from patients with genital herpes simplex virus infection.Protection against lethal challenge of BALB/c mice by passive transfer of monoclonal antibodies to five glycoproteins of herpes simplex virus type 2.Immune responses to labial infection of BALB/c mice with herpes simplex virus type 1.Role of Fc fragments in antibody-mediated recovery from ocular and subcutaneous herpes simplex virus infections.Use of monoclonal antibody directed against herpes simplex virus glycoproteins to protect mice against acute virus-induced neurological diseaseAntibody responses in humans to individual proteins of herpes simplex viruses.Initial herpes simplex virus type 1 infection prevents ganglionic superinfection by other strainsAntigenic variation (mar mutations) in herpes simplex virus glycoprotein B can induce temperature-dependent alterations in gB processing and virus production.Immunogenicity of herpes simplex virus glycoproteins gC and gB and their role in protective immunity.Monoclonal antibodies suppress replication of herpes simplex virus type 1 in trigeminal ganglia.Recovery from lethal herpes simplex virus type 1 infection is mediated by cytotoxic T lymphocytesImmune response to herpes simplex virus infections: virus-specific antibodies in sera from patients with recurrent facial infections.Immune responses in mice against herpes simplex virus: mechanisms of protection against facial and ganglionic infections
P2860
Q27486833-54885F22-6FC2-4443-B59B-829E002E7D4EQ33906594-CD7A93CE-68EA-472F-9A20-948837209C51Q33906859-123CAD26-431A-4A6A-8B37-CD14BE4360C7Q33911628-B243FA93-2E8D-43A6-8E42-859BC2A9442FQ33980379-4F83A850-E9A2-444F-BFD7-D135438CE283Q33981823-D4D4D56C-D633-4610-97E2-4F0E08A39F6BQ35540752-492261A0-8A2C-486A-BF33-9F5400B1CCC4Q36330561-1D124328-1C6F-4244-AC8E-1CEF1374E533Q36333640-D3A8D045-CBC4-41BA-929B-D68F40D68A2EQ36422499-0681B09C-5151-44A1-ABFD-81639F470FCBQ36423892-2BE7BEC2-7D74-42E5-9324-E3459B1C352EQ36429254-B7E0B403-E622-4634-875C-D222E7F76FA8Q36432263-A4A17757-AD3C-4134-981E-A72C774BB908Q36438105-3AC50775-0F62-4476-A1CD-1AB71BE8A81FQ36864290-959BC035-52DF-4F96-A3DE-05D38AC16E74Q36917531-5EAFAB90-FC97-41BF-97C9-60D1D5A0CB24Q36918805-4F72C724-B0CB-417F-A300-55F645AF8DC5Q37109269-671166BC-235C-456C-9AAC-47A9A97D33ECQ40614133-5B9A8C71-C7A0-40CC-BB07-3881D71476CEQ40616009-0DC97B97-CD2A-4F57-B184-5B01645753B1
P2860
Antibody-mediated recovery from subcutaneous herpes simplex virus type 2 infection
description
1978 nî lūn-bûn
@nan
1978年の論文
@ja
1978年学术文章
@wuu
1978年学术文章
@zh-cn
1978年学术文章
@zh-hans
1978年学术文章
@zh-my
1978年学术文章
@zh-sg
1978年學術文章
@yue
1978年學術文章
@zh
1978年學術文章
@zh-hant
name
Antibody-mediated recovery from subcutaneous herpes simplex virus type 2 infection
@en
type
label
Antibody-mediated recovery from subcutaneous herpes simplex virus type 2 infection
@en
prefLabel
Antibody-mediated recovery from subcutaneous herpes simplex virus type 2 infection
@en
P2860
P1476
Antibody-mediated recovery from subcutaneous herpes simplex virus type 2 infection
@en
P2093
Rosemond-Hornbeak H
P2860
P304
P407
P577
1978-08-01T00:00:00Z